Heparin Market Size to Garner $11.01 Billion by 2028 | 6.6% CAGR

As per the report published by Allied Market Research, the global Heparin Market was pegged at $6.53 billion in 2020, and is expected to reach $11.01 billion by 2028, growing at a CAGR of 6.6% from 2021 to 2028.

Surge in incidence of venous thromboembolism and cardiovascular disorders, rise in use of heparin in surgical procedures, and increase in geriatric populations drive the growth of the global heparin market. However, side effects associated with heparin and presence of alternative anticoagulants hinder the market growth. On the contrary, availability of synthetic and semi-synthetic heparin mimetics and R&D activities to develop heparin with improved therapeutics are expected to create lucrative opportunities for the market players in the future.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/6551

Covid-19 scenario:

The heparin market witnessed a modest growth during the pandemic due to rise in use of low molecular weight heparin for Covid-19 treatment.
A large number of patients are suffering from Covid-19 which is linked to respiratory disease. The demand for heparin has increased as it helps to control respiratory inflation and acts as a blood thinner.
The global heparin market is segmented on the basis of product, application, distribution channel, and region. Based on product, the low molecular weight heparin segment held the lion's share in 2020, accounting for more than four-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 6.9% during the forecast period.

On the basis of application, the venous thromboembolism segment dominated in 2020, contributing to more than two-fifths of the market. However, the coronary artery disease segment is expected to manifest the highest CAGR of 7.3% from 2021 to 2028.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/6551

The global heparin market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific is projected to portray the highest CAGR of 7.8% during the forecast period. However, the market across Europe held the largest share in 2020, accounting for nearly half of the market.

The global heparin market includes an in-depth analysis of the prime market players such as B. Braun Holding GmbH & Co. KG, Baxter International Inc., Fresenius SE & Co KGaA, Dr. Reddy's Laboratories Ltd., Leo Pharma A/S, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Trending Reports in Industry:

Implantable Insulin Pump Market-- https://www.alliedmarketresearch.com/implantable-insulin-pump-market

Plasma Fractionation Market-- https://www.alliedmarketresearch.com/plasma-fractionation-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.